DGAP-News
INDUS reaches targets and aims for further growth
DGAP-News: INDUS Holding AG / Key word(s): Final Results
INDUS reaches targets and aims for further growth
21.04.2015 / 11:00
---------------------------------------------------------------------
INDUS reaches targets and aims for further growth
- 2014 sales revenues up 5.8 %; 2014 EBIT up 7.3%
- Successful start to 2015
Bergisch Gladbach, 21 April 2015 - Although the German economy showed a
rather moderate trend last year, the INDUS Group over-achieved its targets
for 2014. This was emphasised by CEO Jürgen Abromeit at today's annual
accounts press conference in Düsseldorf: "We are pleased that all our
segments are moving forward. This shows that our companies are on the right
track."
2014 revenues and earnings exceed expectations
The earnings figures showed an extremely positive trend and exceeded the
company's expectations. Sales revenues reached a record EUR 1,255.7 million
(previous year: EUR 1,186.8 million), which represents an increase by 5.8%.
Over the year, the Group benefited from a consistently stable development,
with the general economic weakness, especially in the third quarter,
primarily offset by the very strong fourth quarter.
The Group's continued operations generated earnings before interest and
taxes (EBIT) of EUR 127.2 million (previous year: EUR 118.6 million). The
EBIT margin improved to 10.1% (previous year: 10.0%). In spite of some
profit-reducing effects, e.g. from the initial consolidation of new
investments and increased interest expenses from minority interests
resulting from the acquisitions, the INDUS shareholders' earnings after
taxes amounted to EUR 63.3 million (previous year: EUR 64.0 million). The
discontinuation of one investment led to a result from discontinued
operations of EUR -4.0 million (previous year: EUR -3.9 million), which
reduced earnings after taxes accordingly. The Board of Management and the
Supervisory Board will propose a EUR 0.10 increase in the dividend to EUR
1.20 to the Annual General Meeting on 3 June.
Continued strong investment activity
INDUS made a total of five transactions in 2014, including selective
additions to the Medical Engineering/Life Science segment and the
Engineering segment in the form of ROLKO and MBN. There were another three
strategic additions at the level of the subsidiaries. Including fixed asset
investments, the Group thus invested a total of EUR 97 million in 2014. The
optimisation of the portfolio structure also included the discontinuation
INDUS reaches targets and aims for further growth
- 2014 sales revenues up 5.8 %; 2014 EBIT up 7.3%
- Successful start to 2015
Bergisch Gladbach, 21 April 2015 - Although the German economy showed a
rather moderate trend last year, the INDUS Group over-achieved its targets
for 2014. This was emphasised by CEO Jürgen Abromeit at today's annual
accounts press conference in Düsseldorf: "We are pleased that all our
segments are moving forward. This shows that our companies are on the right
track."
2014 revenues and earnings exceed expectations
The earnings figures showed an extremely positive trend and exceeded the
company's expectations. Sales revenues reached a record EUR 1,255.7 million
(previous year: EUR 1,186.8 million), which represents an increase by 5.8%.
Over the year, the Group benefited from a consistently stable development,
with the general economic weakness, especially in the third quarter,
primarily offset by the very strong fourth quarter.
The Group's continued operations generated earnings before interest and
taxes (EBIT) of EUR 127.2 million (previous year: EUR 118.6 million). The
EBIT margin improved to 10.1% (previous year: 10.0%). In spite of some
profit-reducing effects, e.g. from the initial consolidation of new
investments and increased interest expenses from minority interests
resulting from the acquisitions, the INDUS shareholders' earnings after
taxes amounted to EUR 63.3 million (previous year: EUR 64.0 million). The
discontinuation of one investment led to a result from discontinued
operations of EUR -4.0 million (previous year: EUR -3.9 million), which
reduced earnings after taxes accordingly. The Board of Management and the
Supervisory Board will propose a EUR 0.10 increase in the dividend to EUR
1.20 to the Annual General Meeting on 3 June.
Continued strong investment activity
INDUS made a total of five transactions in 2014, including selective
additions to the Medical Engineering/Life Science segment and the
Engineering segment in the form of ROLKO and MBN. There were another three
strategic additions at the level of the subsidiaries. Including fixed asset
investments, the Group thus invested a total of EUR 97 million in 2014. The
optimisation of the portfolio structure also included the discontinuation
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte